ADMA BIOLOGICS, INC. Lessee, Operating Lease, Liability, to be Paid, Year One
ADMA BIOLOGICS, INC. (ADMA) had Lessee, Operating Lease, Liability, to be Paid, Year One of $1.03 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-08-05
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $1.03M.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $1.55M.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $1.99M.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $2.58M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2026-06-30 | $1.03M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $1.55M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $1.99M 10-K · filed 2026-02-25 |
| 2025-09-30 | $2.58M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $2.40M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $2.16M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $2.42M 10-K · filed 2025-03-18 |
| 2024-09-30 | $2.42M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $2.42M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $2.42M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $2.40M 10-K · filed 2024-02-28 |
| 2023-09-30 | $2.34M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $2.34M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $2.34M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $2.37M 10-K · filed 2023-03-23 |
| 2022-09-30 | $2.25M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $2.25M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $1.64M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $1.60M 10-K · filed 2022-03-24 |
| 2021-09-30 | $1.51M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $1.51M 10-Q · filed 2021-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |